Organ Care System Market for Heart, by Mode of handling (Portable, Trolley), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2019–2026

Update Available On-Demand

Organ Care System Market for Heart Outlook: 2026

The organ care system market for heart is anticipated to grow rapidly over the forecast period, and is projected to account for $ 37.2 million by 2026, at a 16.5% CAGR, increasing from $ 11.0 million in 2018.

The organ care system is a medical device developed for preserving donor organs for a longer period and this device dispenses required essentials to the organ. Organ care system distributes in the traditional method of preserving organs by maintaining them at the same temperature and environment conditions of the human body. These devices are designed to increase the timeline of the organs outside of the human body, and they will take care of the organs until the transplantation.

Organ Care System Market for Heart Market Drivers:

Increasing number of patients with cardiovascular diseases and rising number of heart transplantations are giving a significant boost to the growth of the global organ care system market for heart

Organ care system (OCS) is enhancing the time period of the organs outside of the human body, and this is increasing the adoption of OCS technology throughout the world. According to the World Health Organization (WHO), around 17.9 million people are suffering from cardiovascular diseases which leads to death. Among the total number of deaths occurring globally, 37% of them die due to cardiovascular disease such as heart failure.

Additionally, rising the number of smokers, physically inactive people, unhealthy diet and high consumption of alcohol will increase blood pressure and cholesterol. This will further lead to heart attacks and heart strokes. Conducting a heart transplant is the only solution in such situations. These factors will significantly enhance the growth of the OCS heart market. Most of the key players are investing in research and development activities, which will further drive the market growth.

Market Restraints:

Lack of awareness about organ donation and high treatment cost are restraining the growth of the Organ Care System Market for Heart

The organ care system heart market size is restrained by high treatment costs to conduct heart transplantation. However, lesser availability of organs for transplantation and fewer timespan to find a correct match will also affect the market growth. This is due to the lack of awareness about organ donation among the people and time needed for the approval of new organ care products in both developed and undeveloped economies. This will further restrict the growth of the OCS market for the heart.

Investment Opportunities in Organ Care System Market for Heart:

Increasing cardiovascular diseases and government concerns will provide significant investment opportunities for the growth of the Organ Care System Market for Heart

Cardiovascular diseases contribute to 37% of all deaths worldwide, heart transplantation is the only solution in such situations. Growing the governmental initiative to increase the awareness regarding organ donation is anticipated to upsurge the market growth Organ care system has created the enormous potential to ensure the whole heart transplant process, which is a complex medical procedure. It is expected that an increasing number of cardiovascular disorders and heart transplants would increase the demand for organ care systems.

Organ Care System Market for Heart, by Mode of Handling Segment:

Trolley based organ care system segment is predicted to be most lucrative till the end of 2026

Source: Research Dive Analysis

The organ care system market for heart is segmented on the basis of mode of handling into portable and trolley. Trolley based organ care system dominated the market, and accounted for $6.3 million in 2018, and expected to reach $19.5 million by the end of 2026. The trolley based system is launched by TransMedics, and this is the only device which received approved from the U.S. Food and Drug Administration (FDA). Over the forecast period, the portable system will witness noteworthy growth in the OCS heart market, due to its portability and easy handling.

Organ Care System Market for Heart, by Region:

Asia-Pacific region will have enormous opportunities for the market investors to grow over the coming years

Europe organ care system market for heart is anticipated to grow rapidly for cardiac organ care systems. This is due to the growing number of market players in the region. The market for Europe is projected to reach $6.5 million by 2026 from $2.8 million in 2018. Along with Europe, Asia Pacific is expected to witness significant growth in the coming timeframe, owing to increasing the government initiatives in India such as the National Organ Transplant program and implementation of organ care system programs in India.

The global market for heart is dominated by North America, and is registered for a highest OCS market share for heart and accounted for $5.2 million in 2018, and anticipated to reach $22.2 million over the forecast period, owing to the presence of major key players and advanced healthcare technology in this region. It is also expected that an increase in the number of heart transplants in the area is anticipated to drive the growth of the industry. According to the United Network for Organ Sharing (UNOS), it has been estimated that in the U.S. there are approximately 7,500 heart transplants performed in 2019 and it is anticipated to increase during the forecast timeframe.

Recent Developments and Key Players in Organ Care System Market for Heart:

Product development and joint ventures are the most common strategies followed by the market players

Source: Research Dive Analysis

The key players of the global organ care system for heart are TransMedics Inc. and Paragonix Technologies Inc. The manufacturers are continuously implementing new approaches, increasing efforts on R&D activities and regional expansions are some of the strategies. In August 2019, TransMedics developed new medical technology, which is an update of “OCSTM Heart”, that is organ transplantation for patients with final stage heart, liver and kidney failure, in order to occupy a maximum share of the global market.

Scope of the Market Report:

Source: Research Dive Analysis